Etizolam, an anti-anxiety agent, attenuates recurrence of chronic subdural hematoma

Neurologia Medico-Chirurgica

Volumn 42, Issue 2, 2002, Pages 53-55

  Hirashima, Yutaka ^a   Kuwayama, Naoya ^a   Hamada, Hideo ^a   Hayashi, Nakamasa ^a   Endo, Shunro ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Chronic subdural hematoma; Etizolam; Platelet activating factor receptor antagonist

Indexed keywords

ANXIOLYTIC AGENT; ETIZOLAM; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ADULT; AGED; ANXIETY NEUROSIS; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG EFFECT; DRUG USE; HUMAN; RECURRENT DISEASE; SUBDURAL HEMATOMA;

EID: 0036189596     PISSN: 04708105     EISSN: None     Source Type: Journal    
DOI: 10.2176/nmc.42.53     Document Type: Article

References (9)

1. Platelet-activating factor (PAF) and the formation of chronic subdural haematoma. Measurement of plasma PAF levels and anti-PAF immunoglobulin titers
2. Platelet-activating factor (PAF) and the development of chronic subdural haematoma
3. Role of local hyperfibrinolysis in the etiology of chronic subdural hematoma
4. Physiopathogenesis of subdural hematomas. Part 1: Histological and biochemical comparisons of subcutaneous hematoma in rats with subdural hematoma in man
5. An antagonistic activity of etizolam on platelet-activating factor (PAF). In vitro effects on platelet aggregation and PAF receptor binding
6. Effect of 6-(o-chlorophenyl)-8-ethyl-1-methyl-4H-s-triazolo[3, 4-c]-thieno[2, 3-e][1, 4]diazepine (Y-7131) on the metabolism of biogenic amines in brain
7. Antagonistic activity of etizolam on platelet-activating factor (PAF). In vivo experiments
8. Pharmacological properties of 6-(o-chlorophenyl)-8-ethyl-1-methyl-4H-s-triazolo[3,4-c]thieno[2,3-e][1,4] diazepine (Y-7131), a new anti-anxiety drug
9. Eosinophil degranulation in the capsule of chronic subdural hematomas